Lee KH[Author] - Search Results

Year	Number of Results
1951	1
1953	2
1957	1
1959	5
1960	2
1962	3
1964	2
1965	2
1966	3
1967	5
1968	6
1969	8
1970	10
1971	5
1972	9
1973	11
1974	5
1975	8
1976	10
1977	13
1978	10
1979	10
1980	11
1981	6
1982	14
1983	10
1984	12
1985	12
1986	17
1987	21
1988	24
1989	24
1990	26
1991	24
1992	31
1993	42
1994	54
1995	48
1996	71
1997	78
1998	77
1999	104
2000	125
2001	124
2002	119
2003	188
2004	250
2005	266
2006	274
2007	347
2008	328
2009	376
2010	413
2011	508
2012	547
2013	554
2014	529
2015	578
2016	553
2017	559
2018	502
2019	521
2020	577
2021	180

1

Overall Survival with Osimertinib in Untreated, EGFR-Mutated Advanced NSCLC.

Ramalingam SS, Vansteenkiste J, Planchard D, Cho BC, Gray JE, Ohe Y, Zhou C, Reungwetwattana T, Cheng Y, Chewaskulyong B, Shah R, Cobo M, Lee KH, Cheema P, Tiseo M, John T, Lin MC, Imamura F, Kurata T, Todd A, Hodge R, Saggese M, Rukazenkov Y, Soria JC; FLAURA Investigators. Ramalingam SS, et al. Among authors: lee kh. N Engl J Med. 2020 Jan 2;382(1):41-50. doi: 10.1056/NEJMoa1913662. Epub 2019 Nov 21. N Engl J Med. 2020. PMID: 31751012 Clinical Trial.

2

Seven recommendations to rescue the patients and reduce the mortality from COVID-19 infection: An immunological point of view.

Kronbichler A, Effenberger M, Eisenhut M, Lee KH, Shin JI. Kronbichler A, et al. Among authors: lee kh. Autoimmun Rev. 2020 Jul;19(7):102570. doi: 10.1016/j.autrev.2020.102570. Epub 2020 May 3. Autoimmun Rev. 2020. PMID: 32376397 Free PMC article. Review.

3

Durvalumab With or Without Tremelimumab vs Standard Chemotherapy in First-line Treatment of Metastatic Non-Small Cell Lung Cancer: The MYSTIC Phase 3 Randomized Clinical Trial.

Rizvi NA, Cho BC, Reinmuth N, Lee KH, Luft A, Ahn MJ, van den Heuvel MM, Cobo M, Vicente D, Smolin A, Moiseyenko V, Antonia SJ, Le Moulec S, Robinet G, Natale R, Schneider J, Shepherd FA, Geater SL, Garon EB, Kim ES, Goldberg SB, Nakagawa K, Raja R, Higgs BW, Boothman AM, Zhao L, Scheuring U, Stockman PK, Chand VK, Peters S; MYSTIC Investigators. Rizvi NA, et al. Among authors: lee kh. JAMA Oncol. 2020 May 1;6(5):661-674. doi: 10.1001/jamaoncol.2020.0237. JAMA Oncol. 2020. PMID: 32271377 Free PMC article. Clinical Trial.

4

Chest Radiographic and CT Findings of the 2019 Novel Coronavirus Disease (COVID-19): Analysis of Nine Patients Treated in Korea.

Yoon SH, Lee KH, Kim JY, Lee YK, Ko H, Kim KH, Park CM, Kim YH. Yoon SH, et al. Among authors: lee kh. Korean J Radiol. 2020 Apr;21(4):494-500. doi: 10.3348/kjr.2020.0132. Epub 2019 Feb 26. Korean J Radiol. 2020. PMID: 32100485 Free PMC article.

5

Immunopathogenesis of ANCA-Associated Vasculitis.

Kronbichler A, Lee KH, Denicolò S, Choi D, Lee H, Ahn D, Kim KH, Lee JH, Kim H, Hwang M, Jung SW, Lee C, Lee H, Sung H, Lee D, Hwang J, Kim S, Hwang I, Kim DY, Kim HJ, Cho G, Cho Y, Kim D, Choi M, Park J, Park J, Tizaoui K, Li H, Smith L, Koyanagi A, Jacob L, Gauckler P, Shin JI. Kronbichler A, et al. Among authors: lee kh. Int J Mol Sci. 2020 Oct 3;21(19):7319. doi: 10.3390/ijms21197319. Int J Mol Sci. 2020. PMID: 33023023 Free PMC article. Review.

6

COVID-19: maintaining essential rehabilitation services across the care continuum.

Prvu Bettger J, Thoumi A, Marquevich V, De Groote W, Rizzo Battistella L, Imamura M, Delgado Ramos V, Wang N, Dreinhoefer KE, Mangar A, Ghandi DBC, Ng YS, Lee KH, Tan Wei Ming J, Pua YH, Inzitari M, Mmbaga BT, Shayo MJ, Brown DA, Carvalho M, Oh-Park M, Stein J. Prvu Bettger J, et al. Among authors: lee kh. BMJ Glob Health. 2020 May;5(5):e002670. doi: 10.1136/bmjgh-2020-002670. BMJ Glob Health. 2020. PMID: 32376777 Free PMC article. No abstract available.

7

Major clinical research advances in gynecologic cancer in 2019.

Kim M, Suh DH, Lee KH, Eom KY, Lee JY, Lee YY, Hansen HF, Mirza MR, Kim JW. Kim M, et al. Among authors: lee kh. J Gynecol Oncol. 2020 May;31(3):e48. doi: 10.3802/jgo.2020.31.e48. J Gynecol Oncol. 2020. PMID: 32319232 Free PMC article. Review.

8

Atezolizumab with or without bevacizumab in unresectable hepatocellular carcinoma (GO30140): an open-label, multicentre, phase 1b study.

Lee MS, Ryoo BY, Hsu CH, Numata K, Stein S, Verret W, Hack SP, Spahn J, Liu B, Abdullah H, Wang Y, He AR, Lee KH; GO30140 investigators. Lee MS, et al. Among authors: lee kh. Lancet Oncol. 2020 Jun;21(6):808-820. doi: 10.1016/S1470-2045(20)30156-X. Lancet Oncol. 2020. PMID: 32502443 Clinical Trial.

9

Brigatinib Versus Crizotinib in Advanced ALK Inhibitor-Naive ALK-Positive Non-Small Cell Lung Cancer: Second Interim Analysis of the Phase III ALTA-1L Trial.

Camidge DR, Kim HR, Ahn MJ, Yang JCH, Han JY, Hochmair MJ, Lee KH, Delmonte A, García Campelo MR, Kim DW, Griesinger F, Felip E, Califano R, Spira A, Gettinger SN, Tiseo M, Lin HM, Gupta N, Hanley MJ, Ni Q, Zhang P, Popat S. Camidge DR, et al. Among authors: lee kh. J Clin Oncol. 2020 Nov 1;38(31):3592-3603. doi: 10.1200/JCO.20.00505. Epub 2020 Aug 11. J Clin Oncol. 2020. PMID: 32780660 Clinical Trial.

10

Asymptomatic patients as a source of COVID-19 infections: A systematic review and meta-analysis.

Kronbichler A, Kresse D, Yoon S, Lee KH, Effenberger M, Shin JI. Kronbichler A, et al. Among authors: lee kh. Int J Infect Dis. 2020 Sep;98:180-186. doi: 10.1016/j.ijid.2020.06.052. Epub 2020 Jun 17. Int J Infect Dis. 2020. PMID: 32562846 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results